SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.0001000+899.9%Aug 15 3:35 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Janet Madison who wrote (575)8/20/1997 9:38:00 AM
From: Graham Marshman   of 1359
 
I assume everyone has seen this one - good plug.

biz.yahoo.com

For example, he said shares of Interneuron Pharmaceuticals Inc (IPIC) have barely budged since the company last month announced favorable results in
its second Phase III clinical trial for citicoline, its drug candidate for stroke.

``Here's a drug with almost no toxicity that may have a market of $300 million to $400 million by the year 2000. And people didn't respond,'' Tracy said,
noting the company has said it intends to file a new drug application with the FDA later this year.

Graham
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News